SHARON JACKSON: Open Payments
NPI 1447799390 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,402 in 130 payments from 22 companies in 2025. Trend: 2023 $2,822 · 2024 $2,807 · 2025 $2,402
Food & beverage: $2,402
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $558 |
| Lilly USA, LLC | 14 | $286 |
| PFIZER INC. | 16 | $251 |
| Corcept Therapeutics | 5 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $158 |
| Ardelyx, Inc. | 6 | $142 |
| GlaxoSmithKline, LLC. | 7 | $138 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Vanda Pharmaceuticals Inc. | 4 | $125 |
| SCILEX PHARMACEUTICALS INC. | 6 | $105 |
Products named: VRAYLAR, Korlym, QULIPTA, Kerendia, MOUNJARO, IBSRELA, TRELEGY ELLIPTA, FANAPT.
Industry payments across LA — which companies pay providers there.
